Apellis Pharmaceuticals I...

22.64
0.77 (3.52%)
At close: Apr 01, 2025, 3:59 PM
22.24
-1.75%
After-hours: Apr 01, 2025, 05:17 PM EDT

Apellis Pharmaceuticals Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 411.29M 351.19M 551.8M 640.19M 565.78M
Short-Term Investments n/a 1.11M 6.5M 60.36M 311.87M
Long-Term Investments n/a 3.24M n/a n/a n/a
Other Long-Term Assets 77.06M -1.93M 15.8M 31.64M 18.86M
Receivables 264.93M 206.44M 7.73M 10.1M 25M
Inventory 81.4M 146.36M 85.71M 16.29M 1.00
Other Current Assets 31.33M 22.41M 36.66M 72.24M 11.14M
Total Current Assets 788.95M 766.33M 719.52M 824.05M 917.19M
Property-Plant & Equipment 19.04M 21.09M 24.89M 26.08M 24.52M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 96.1M 22.4M 40.69M 57.72M 43.38M
Total Assets 885.05M 788.73M 760.22M 881.76M 960.57M
Account Payables 38.57M 37.52M 37.34M 16.91M 8.48M
Deferred Revenue n/a n/a n/a 103.24M 111.94M
Short-Term Debt 6.75M n/a n/a n/a n/a
Other Current Liabilities 133.43M 75.83M 81.43M 7.58M 4.23M
Total Current Liabilities 185.51M 247.59M 167.61M 131.85M 128.33M
Long-Term Debt 452.83M 93.03M 92.74M 189.02M 358.83M
Other Long-Term Liabilities 7.97M 242.13M 315.65M 345.15M 253.64M
Total Long-Term Liabilities 471M 346.62M 422.74M 551.26M 627.68M
Total Liabilities 656.51M 594.21M 590.35M 683.1M 756.01M
Total Debt 469.78M 110.93M 112.71M 210.22M 377.73M
Common Stock 12K 12K 11K 10K 8K
Retained Earnings -3.04B -2.84B -2.31B -1.66B -926.35M
Comprehensive Income -3.31M -3.54M -875K -2.09M -117K
Shareholders Equity 228.54M 194.52M 169.87M 198.66M 204.56M
Total Investments n/a 4.35M 6.5M 60.36M 311.87M